EHE Health Launches Innovative VO2 Max Testing for Preventive Care
EHE Health, a national preventive healthcare provider, has recently unveiled a groundbreaking VO2 max testing innovation in the United States. This pioneering technology seeks to significantly enhance patient understanding and management of their health.
Understanding the Revolutionary Seismofit® Sensor
At the heart of this innovation is the Seismofit® sensor, developed by VentriJect, a forward-thinking technology firm from Denmark. This sensor offers a clinically relevant VO2 max reading in under three minutes without requiring any form of exercise. Such a transformative approach to assessing VO2 max represents a considerable leap forward, especially for older adults and those with physical restrictions.
How Does Seismofit® Work?
The Seismofit® sensor gauges cardiorespiratory fitness (CRF) through a process called seismocardiography. This sophisticated technique employs a small sensor to observe the movements in the chest triggered by the heartbeat. It processes this data using an advanced proprietary algorithm to provide a clinically validated estimation of VO2 max, a vital indicator of CRF.
The Importance of VO2 Max
VO2 max measures the maximum amount of oxygen consumed during exercise, expressed in millilitres of oxygen per minute per kilogram of body weight. Considered the gold standard for gauging cardiorespiratory fitness, VO2 max plays a crucial role in reflecting overall health. Numerous health conditions correlate with VO2 max levels; the American Heart Association advocates for regular VO2 max assessments as it is the 'strongest indicator of health.'
Global Adoption of Seismofit®
While the Seismofit® technology has found adoption across Europe, the launch in the United States marks a significant milestone in its accessibility. This innovative solution perfectly complements EHE Health's existing heart health protocols, further enhancing the capabilities they offer to patients.
Expert Insights on the Innovation
Dr. Jacqueline King, Chief Medical Officer of EHE Health, emphasized the impact of this technological advancement on patient assessments. She stated, "We are thrilled to introduce this evolution in cardiovascular evaluation to our patient base. Unlike traditional methods, resting VO2 max offers a precise and inclusive approach to assess fitness levels for individuals of varying activity levels. As the pioneering national provider network to implement this technology, EHE Health continues to push boundaries in preventive care delivery."
Additionally, EHE Health’s CEO, Greg Mansur, affirmed that this advancement is a testament to the company’s ongoing commitment to enhancing preventive care services. He noted, "This progression underscores EHE Health's dedication to refining our clinical practices and empowering patients to take charge of their long-term health."
Collaboration with VentriJect
Mikkel Kristiansen, CEO of VentriJect, shared his enthusiasm about collaborating with EHE Health, stating, "We are elated to partner with EHE Health in delivering this innovative solution to American patients. While VO2 max is a routine metric for elite athletes, its integration into regular healthcare remains limited despite its recognized importance. The partnership with EHE Health signifies a crucial step in our North American expansion goals."
Dr. Kristiansen further highlighted EHE Health's expertise in preventive healthcare, expressing optimism about how the Seismofit® technology will enable patients to manage their health better.
Implementation Across EHE Health Clinics
The new VO2 max testing rollout is underway in EHE Health managed clinics and major network locations, with comprehensive implementation anticipated by mid-2026. This initiative marks an exciting chapter in the journey of preventive healthcare for EHE Health.
About EHE Health
EHE Health, based in New York City, represents a national preventive healthcare provider network focused on partnering with mid- and large-sized employers. The organization facilitates an entry point into organized healthcare, emphasizing prevention. EHE Health has garnered accolades from Fortune Magazine and Great Place to Work® as one of the Best Workplaces in the healthcare sector, leveraging over 100 years of experience in integrating personalized preventive care. The network boasts more than 200 health clinics nationwide, staffed by a team of highly skilled primary care physicians and clinicians.
About VentriJect
Founded in 2018 as a spin-out from Aalborg University, VentriJect is a Danish technology firm dedicated to revolutionizing how cardiorespiratory fitness is assessed. Through its clinically validated and patented technology, Seismofit®, the company aims to transform the landscape of health and wellness measurement.
Frequently Asked Questions
What is VO2 max and why is it important?
VO2 max is the maximum amount of oxygen a person can utilize during exercise and serves as a critical indicator of cardiorespiratory fitness and overall health.
How does the Seismofit® sensor work?
The Seismofit® sensor assesses heart movements using seismocardiography to deliver accurate VO2 max readings without exercise.
Who can benefit from VO2 max testing?
Individuals of all activity levels, particularly older adults or those with physical limitations, can benefit from the accessibility of VO2 max testing.
When will the VO2 max test be available?
The implementation of the VO2 max test across clinics is expected to be completed by mid-2026.
What is EHE Health's goal with the new testing?
EHE Health aims to equip patients with valuable health insights to better understand and manage their long-term health.
